Within hours of returning to office, in January 2025, U.S. President Donald Trump took an axe to multilateralism by pulling the United States out of the Paris climate accord and the World Health ...

The world’s polar bear population is projected to decline by two-thirds by 2050. A new study from the University of East Anglia suggests that polar bears are undergoing rapid genetic changes, and ...

With climate change steadily dismantling the icy habitat essential to their existence, new research suggests polar bears are rapidly rewiring their own genetics in a bid to survive. The species is ...

For over 5 years, Arthur has been professionally covering video games, writing guides and walkthroughs. His passion for video games began at age 10 in 2010 when he first played Gothic, an immersive ...

We Had A Surprise Guest In Roblox Murder Mystery - JeromeASF Roblox Epstein mentioned Trump multiple times in private emails, new release shows Is Jackie Chan dead? Here’s what we know Trump Suffers ...

Layoffs are spreading, making it more likely you or someone you know has lost a job. Losing a job can be traumatic, but it doesn't have to ruin your finances, experts said. Staying calm and quickly ...

The BBC will be forced to broadcast a statement live on television after UK media regulator Ofcom ruled that Gaza: How to Survive a Warzone was “materially misleading.” The BBC has already ...

The waters surrounding New York allowed it to grow into an economic powerhouse. But what has been a blessing is increasingly a threat, as flooding becomes one of the city’s greatest challenges. A map ...

Francis Wilkinson is a Bloomberg Opinion columnist covering US politics and policy. Previously, he was executive editor for the Week and a writer for Rolling Stone. Save On a Thursday evening in early ...

WASHINGTON — President Trump revealed his “big plans” for the midterms include a desire to “survive” amid left-wing violence. The president said the morbid line during an interview with One America ...

Cylembio combined with Keytruda improved progression-free survival in advanced melanoma, achieving 19.4 months versus 11.0 months with Keytruda alone. PD-L1 negative patients showed significant ...